Free Trial
NASDAQ:COYA

Coya Therapeutics (COYA) Stock Price, News & Analysis

Coya Therapeutics logo
$6.24 +0.02 (+0.32%)
As of 11:31 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Coya Therapeutics Stock (NASDAQ:COYA)

Key Stats

Today's Range
$5.97
$6.34
50-Day Range
$5.32
$6.41
52-Week Range
$4.65
$10.24
Volume
25,025 shs
Average Volume
72,607 shs
Market Capitalization
$104.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.50
Consensus Rating
Buy

Company Overview

Coya Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
47th Percentile Overall Score

COYA MarketRank™: 

Coya Therapeutics scored higher than 47% of companies evaluated by MarketBeat, and ranked 588th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Coya Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Coya Therapeutics has only been the subject of 4 research reports in the past 90 days.

  • Read more about Coya Therapeutics' stock forecast and price target.
  • Earnings Growth

    Earnings for Coya Therapeutics are expected to decrease in the coming year, from ($1.15) to ($1.47) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Coya Therapeutics is -5.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Coya Therapeutics is -5.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Coya Therapeutics has a P/B Ratio of 2.63. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Coya Therapeutics' valuation and earnings.
  • Percentage of Shares Shorted

    1.68% of the float of Coya Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Coya Therapeutics has a short interest ratio ("days to cover") of 4.6.
  • Change versus previous month

    Short interest in Coya Therapeutics has recently decreased by 9.15%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Coya Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Coya Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.68% of the float of Coya Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Coya Therapeutics has a short interest ratio ("days to cover") of 4.6.
  • Change versus previous month

    Short interest in Coya Therapeutics has recently decreased by 9.15%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Coya Therapeutics has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Coya Therapeutics this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Coya Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.00% of the stock of Coya Therapeutics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 39.75% of the stock of Coya Therapeutics is held by institutions.

  • Read more about Coya Therapeutics' insider trading history.
Receive COYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Coya Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

COYA Stock News Headlines

Why Volatility Keeps Coming Back — And How I Trade It
Volatility isn’t the enemy — it’s the opportunity. While most traders panic during market swings, Jeff Clark uses a three-step method to target quick wins from VIX spikes and sudden price moves. It works in any market direction… and he’s showing how it works in a free video, available now.
Coya Therapeutics Inc News - Morningstar
See More Headlines

COYA Stock Analysis - Frequently Asked Questions

Coya Therapeutics' stock was trading at $5.73 at the beginning of the year. Since then, COYA shares have increased by 8.9% and is now trading at $6.24.

Coya Therapeutics, Inc. (NASDAQ:COYA) posted its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.44) EPS for the quarter, hitting analysts' consensus estimates of ($0.44). The business earned $257.88 million during the quarter, compared to analysts' expectations of $2.63 million.

Coya Therapeutics (COYA) raised $15 million in an initial public offering (IPO) on Thursday, December 29th 2022. The company issued 3,050,000 shares at $5.00 per share.

Shares of COYA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Coya Therapeutics investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), Disc Medicine (IRON), Jabil (JBL), Adobe (ADBE) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
5/13/2025
Today
7/10/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:COYA
CIK
1835022
Fax
N/A
Employees
6
Year Founded
N/A

Price Target and Rating

High Price Target
$18.00
Low Price Target
$14.00
Potential Upside/Downside
+164.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.88 million
Net Margins
N/A
Pretax Margin
-484.56%
Return on Equity
-48.88%
Return on Assets
-43.32%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.84
Quick Ratio
8.84

Sales & Book Value

Annual Sales
$3.55 million
Price / Sales
29.41
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.37 per share
Price / Book
2.63

Miscellaneous

Outstanding Shares
16,730,000
Free Float
14,718,000
Market Cap
$104.40 million
Optionable
Not Optionable
Beta
0.26
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:COYA) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners